Chronic active hepatitis: a sixteen year survey at a district general hospital
- 1 October 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 65 (768) , 725-728
- https://doi.org/10.1136/pgmj.65.768.725
Abstract
Summary: Over a period of 16 years (1971-87) all cases of chronic active hepatitis (CAH) diagnosed following liver biopsy have been reviewed to assess incidence, aetiology, outcome and response to treatment. North Tees District serves a population of 210,000 and 26 cases were identified (20 female) age range 9-73 years (median 56 years). Incidence remained constant at 1:100,000/year. Twenty cases (77%) had an immune aetiology. Other aetiologies were hepatitis B virus (HBV) infection, alpha-1AT deficiency, non-A non-B hepatitis and a complex multisystem disease. The median follow-up period was 50 months. There were 7 deaths, three unrelated to liver disease. Survival analysis gives an 86% 5-year survival and 56% 10-year survival. Twenty four patients were treated with steroids (and 6 additionally with azathioprine); 15 (63%) were steroid responsive and 9 were non-responsive. In five patients steroids were successfully discontinued but in 10 patients severe symptomatic relapse occurred on steroid reduction below 7.5-10 mg/day. Steroid non-responders were not typical CAH, 5 with predominantly a rise in alkaline phosphatase, one multisystem disease and one HBV positive. Steroid discontinuation was only possible in one third of the patients responding. Eighteen subjects (69%) were cirrhotic at initial biopsy; 9 had follow-up biopsies, 6 were unchanged but three had progressed to cirrhosis despite apparent steroid responsiveness.This publication has 18 references indexed in Scilit:
- ANTIBODIES TO LIVER-SPECIFIC PROTEIN PREDICT OUTCOME OF TREATMENT WITHDRAWAL IN AUTOIMMUNE CHRONIC ACTIVE HEPATITISThe Lancet, 1984
- Relapse Following Treatment Withdrawal in Patients with Autoimmune Chronic Active HepatitisHepatology, 1983
- CHRONIC ACTIVE HEPATITIS: THE SPECTRUM OF DISEASEThe Lancet, 1982
- Deleterious Effect of Prednisolone in HBsAg-positive Chronic Active HepatitisNew England Journal of Medicine, 1981
- Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis.Gut, 1980
- Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.Gut, 1976
- Responses to Treatment can Differentiate Chronic Active Liver Disease with Cholangitic Features from the Primary Biliary Cirrhosis SyndromeGastroenterology, 1976
- CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITISThe Lancet, 1973
- Chronic active liver diseaseHuman Pathology, 1972
- Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic HepatitisQJM: An International Journal of Medicine, 1971